Sumatriptan
Product Images NDC 67296-1687

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 67296-1687). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

A line graph showing the estimated probability of response over time in minutes from the initial dose for Sumatriptan at dosages of 25 mg, 50 mg, 100 mg, and placebo. The graph illustrates increased response probabilities over time, with higher dosages generally showing higher response rates compared to placebo.*

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Poo (Sumatriptan Fig2)

A line graph showing the estimated probability of headache pain remission or relief over 24 hours from the initial dose. The graph compares placebo with Sumatriptan doses of 25 mg, 50 mg, and 100 mg, illustrating dose-dependent efficacy over time.*

FDA Label Image

Package Label-principal Display Panel (25 mg (36 Tablets Bottle))

Label for Sumatriptan Tablets USP 25 mg, showing active ingredient strength and dosage form. The label includes directions to swallow tablets whole with water and storage instructions. It is marked Rx only and manufactured by Aurobindo Pharma USA, Inc., with a count of 36 tablets and a barcode on the right.*

FDA Label Image

Package Label-principal Display Panel (25 mg Blister Carton (9 Unit-dose))

Packaging label for Sumatriptan Tablets, USP 25 mg by RedPharm Drug. The label shows 9 unit-dose tablets with instructions for use and storage. It includes details such as the drug name, dosage strength, NDC 65862-146-36, manufacturer Aurobindo Pharma USA, and directions for handling the unit-dose packaging.*

FDA Label Image

Package Label-principal Display Panel (50 mg (36 Tablets Bottle))

Sumatriptan Tablets, USP 50 mg label shows the active ingredient sumatriptan succinate equivalent to 50 mg sumatriptan per tablet. The label indicates 36 tablets per package and includes storage information and distribution by Aurobindo Pharma USA, Inc. It also features a barcode and printer coding areas.*

FDA Label Image

Package Label-principal Display Panel (50 mg Blister Carton (9 Unit-dose))

Packaging label for Sumatriptan Tablets, USP 50 mg by RedPharm Drug. The label indicates the tablets are available as 9 unit-dose tablets and prominently displays the strength (50 mg). The label includes manufacturer details (Aurobindo Pharma USA, Inc.) and storage instructions. The NDC displayed is 65862-147-36, with usage instructions and a tear strip illustration on the package.*

FDA Label Image

Package Label-principal Display Panel (100 mg (36 Tablets Bottle))

Packaging label for Sumatriptan Tablets, USP 100 mg by Aurobindo Pharma USA, showing a bottle containing 36 tablets. Label includes instructions to swallow tablets whole, storage conditions, and distributor information in East Windsor, NJ.*

FDA Label Image

Package Label-principal Display Panel (100 mg Blister Carton (9 Unit-dose))

Packaging label for Sumatriptan Tablets USP 100 mg, 9 unit-dose tablets, labeled by RedPharm Drug and manufactured by Aurobindo Pharma USA, Inc. The label includes dosage strength, tablet count, storage instructions, and barcode. It features instructions with illustrations on how to open the unit-dose blister packaging.*

FDA Label Image

Chemical Structure (Sumatriptan Str)

Chemical structure diagram of Sumatriptan showing its indole core with a sulfonamide group, a substituted ethylamino side chain, and a carboxyl group attached to the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.